Drug Trial Radar · NCT05351801
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Jun 21, 2023
Primary completion
Sep 29, 2028
Study completion May 31, 2029
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Apr 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Chronic neuropathic pain (CNP) is disabling. Research on frontline treatments for CNP, shows inconsistent outcomes and dissatisfaction among Veterans. Veterans and clinicians have shown significant interest in cannabis derivatives (THC, CBD) for neuropathic pain control, but there are no well-controlled trials guiding expectations for benefit and adverse outcomes associated with cannabis for CNP. Because Veterans are likely to present with pain and pain-related polymorbidity significantly differing from that of civilians, a well-structured clinical trial of cannabinoids for Veterans with CNP is vital.
Conditions
- Neuropathic Pain
- Peripheral Neuropathic Pain
Interventions
THC (Syndros)Drug
Participants will receive a target dose of 10mg per day of THC (Syndros).
CBD (Epidolex)Drug
Participants will receive a target dose of 800 mg per day of CBD (Epidolex).
THC + CBD (Nabiximols)Drug
Participants will receive a target dose of 10.8 mg / 10 mg per day of THC + CBD (Nabiximols).
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare the short-term efficacy of THC, CBD, or THC+CBD vs Placebo on Neuropathic Pain as measured by the Numeric Rating Scale of PainTime frame: Baseline, Week 6
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
VA San Diego Healthcare System, San Diego, CA
San Diego, California · Recruiting
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California · Active not recruiting
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut · Recruiting
Providence VA Medical Center, Providence, RI
Providence, Rhode Island · Recruiting
South Texas Health Care System, San Antonio, TX
San Antonio, Texas · Recruiting
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington · Terminated
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.